-
-
-
-
-
-
-
/C O R R E C T I O N -- UCB/
-
-
-
-
-
-
-
United Community Banks, Inc. Reports Third Quarter Earnings
-
-
-
-
-
-
-
UCB's HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment
-
-
-
-
-
-
-
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity
-
-
-
-
-
-
-
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
-
-
-
-
-
-
-
Raymond James Upgrades United Community Banks (UCB) to Outperform
-
-
-
-
-
-
-
Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

